Personalised Approach to Diagnosing and Managing Ischemic Stroke with a Plasma-Soluble Urokinase-Type Plasminogen Activator Receptor.

MLA

Śmiłowska, Katarzyna, et al. “Personalised Approach to Diagnosing and Managing Ischemic Stroke with a Plasma-Soluble Urokinase-Type Plasminogen Activator Receptor.” Journal of Personalized Medicine, vol. 12, no. 3, Mar. 2022, p. 457–N.PAG. EBSCOhost, https://doi.org/10.3390/jpm12030457.

APA

Śmiłowska, K., Śmiłowski, M., Partyka, R., Kokocińska, D., & Jałowiecki, P. (2022). Personalised Approach to Diagnosing and Managing Ischemic Stroke with a Plasma-Soluble Urokinase-Type Plasminogen Activator Receptor. Journal of Personalized Medicine, 12(3), 457–N.PAG. https://doi.org/10.3390/jpm12030457

Chicago

Śmiłowska, Katarzyna, Marek Śmiłowski, Robert Partyka, Danuta Kokocińska, and Przemysław Jałowiecki. 2022. “Personalised Approach to Diagnosing and Managing Ischemic Stroke with a Plasma-Soluble Urokinase-Type Plasminogen Activator Receptor.” Journal of Personalized Medicine 12 (3): 457–N.PAG. doi:10.3390/jpm12030457.